Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2873118 | The Annals of Thoracic Surgery | 2013 | 6 Pages |
Abstract
We conclude that in human IMA, azelnidipine has a potent inhibitory effect on the vasoconstriction mediated by a variety of vasoconstrictors. Thus, use of azelnidipine in CABG patients is favored for treating and preventing graft spasm.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Ge MD, PhD, Xiao-Cheng MD, Wen-Bin MD, Qin MD, PhD, Guo-Wei MD, PhD,